Business Of Biotech cover image

Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Business Of Biotech

00:00

Modality strategy: multispecifics and small molecules

Cyril outlines using the right modality, IGI's CBLB small molecule, and combination opportunities with multispecifics.

Play episode from 34:08
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app